Erasmus Medical Center
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Erasmus Medical Center sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Erasmus Medical Center: 5 sponsored US clinical trials, 3 recruiting.
Erasmus Medical Center sponsors 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 2 completed. The most-studied condition in this pipeline is Glioblastoma, with 2 trials.
Upper-quartile sponsor footprint
Erasmus Medical Center sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
NCT06273176
The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections
NCT04708171
Balloon vs. Self Expanding Transcatheter Valve for Degenerated Bioprosthesis
NCT04843072
Fast Assessment of STenosis Severity- FASTII Study
NCT03791320
International Guillain-Barré Syndrome Outcome Study
NCT01582763
What is open in the Erasmus Medical Center pipeline
3 recruiting of 5 indexed (60% open); 2 completed (40%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Glioblastoma (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Erasmus Medical Center: open-pipeline peers nationwide
Peers matched on 5 registered trials and 60% open enrollment, not the therapeutic-area sidebar.
Erasmus Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 60% open enrollment (± trial volume)
- Alaska Native Tribal Health Consortium · 60% recruiting · 5 trials
- Anwaar Saeed · 60% recruiting · 5 trials
- Autolus Limited · 60% recruiting · 5 trials
- Beam Therapeutics · 60% recruiting · 5 trials
Related
What to do with this Erasmus Medical Center page
5 registered trials is a research-attention snapshot, not an endorsement of Erasmus Medical Center or any single study.
- 3 of Erasmus Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Glioblastoma is the condition Erasmus Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Glioblastoma trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Erasmus Medical Center pipeline card: 5 registered trials from official public datasets.Report a data error.